Page last updated: 2024-10-30

6-anilino-5,8-quinolinedione and Akinetic-Rigid Variant of Huntington Disease

6-anilino-5,8-quinolinedione has been researched along with Akinetic-Rigid Variant of Huntington Disease in 1 studies

6-anilino-5,8-quinolinedione: structure given in first source; SRS-A & guanylate cyclase antagonist
6-anilino-5,8-quinolinedione : A quinolone that is quinoline-5,8-dione in which the hydrogen at position 6 is replaced by an anilino group.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sarkar, S1
Perlstein, EO1
Imarisio, S1
Pineau, S1
Cordenier, A1
Maglathlin, RL1
Webster, JA1
Lewis, TA1
O'Kane, CJ1
Schreiber, SL1
Rubinsztein, DC1

Other Studies

1 other study available for 6-anilino-5,8-quinolinedione and Akinetic-Rigid Variant of Huntington Disease

ArticleYear
Small molecules enhance autophagy and reduce toxicity in Huntington's disease models.
    Nature chemical biology, 2007, Volume: 3, Issue:6

    Topics: Animals; Autophagy; Huntington Disease; Mammals; Models, Biological; Neuroprotective Agents; Sacchar

2007